BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Guerbet 

BP 50400
95943 Roissy CdG
Cedex      France
Phone: 331-45-91-51-49 Fax: 331-45-91-76-69


SEARCH JOBS




Industry
Medical Device


Collaborations

Advanced Magnetics, Inc.  Feridex I.V. (under the tradename EndoremTM), GastroMARK (under the tradename LumiremTM), Combidex (under the tradename SineremTM) in western Europe and Brazil





 Company News
Guerbet (GBT): 2014 First-Half Results 7/30/2014 8:18:38 AM
Guerbet (GBT) Release: FDA Approves Lipiodol® (Ethiodized Oil) Injection For Imaging Of Tumors In Adults With Known Hepatocellular Carcinoma (HCC) 4/11/2014 8:51:55 AM
Guerbet (GBT) Receives FDA Approval For A New Manufacturing Plant For Lipiodol® (Ethiodized Oil) Injection 2/20/2014 6:54:17 AM
Guerbet (GBT) Release: FDA Grants Orphan Drug Designation to Lipiodol® (Ethiodized Oil) Injection for Management of Patients with Known Hepatocellular Carcinoma (HCC) 10/21/2013 10:18:25 AM
Guerbet (GBT) Release: First Injection of Dotarem® (Gadoterate Meglumine) in US Performed at Cincinnati Children's Hospital Medical Center 7/26/2013 8:27:41 AM
FDA Approves Guerbet (GBT)'s New Gadolinium-Based MRI Agent 3/21/2013 9:08:07 AM
Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet (GBT) NDA for Dotarem® (gadoterate meglumine) 2/15/2013 9:36:50 AM
Guerbet (GBT) - Another Proof That There Is No Difference Between Low-Osmolarity Contrast Agents And Iso-Osmolar Agent For Prevention Of Contrast-Induced Nephropathy 10/27/2006 2:38:29 PM